BB's Stock Haven

[Ronin]

MYMX .039 Coronavirus play... Malaria & HIV vaccines their specialty!

Float: 80M
No R/S:
$8M funding last year:

https://www.otcmarkets.com/stock/MYMX/news/Mymetics-Receives-Funding-from-NIH-for-Novel-HIV-Vaccine-Study?id=226130

Very legitimate company:

https://www.otcmarkets.com/stock/MYMX/profile


MYMX pipeline...

https://www.mymetics.com/vaccine-pipeline

MYMETICS' MALARIA VACCINE APPROACH

Mymetics’ first malaria vaccine candidate is using the influenza virosome as the carrier and adjuvant with the incorporation of at least three antigens that target the two forms of the parasite and is thereby one of the few vaccine developed with this approach

The second malaria vaccine candidate is a transmission blocking vaccine which also uses the Mymetics virosome technology by incorporating a transmission blocking antigen from the Laboratory of Malaria Immunology and Vaccinology (LMIV) of the NIAID.

The transmission-blocking vaccine candidate seek to interrupt the life cycle of the parasite by inducing antibodies that prevent the parasite from maturing in the mosquito after it takes a blood meal from a vaccinated person.

Malaria vaccines being strongly considered...

https://www.cnbc.com/2020/03/27/coronavirus-vaccine-novartis-ceo-says-its-too-soon-to-know-whether-malaria-drugs-can-work.html